Eczema Clinical Trials

48 recruitingLast updated: June 18, 2026

There are 48 actively recruiting eczema clinical trials across 26 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 4, Phase 1. Top locations include Montreal, Quebec, Canada, Bethesda, Maryland, United States, New Taipei City, Taiwan. Updated daily from ClinicalTrials.gov.


Eczema Trials at a Glance

48 actively recruiting trials for eczema are listed on ClinicalTrialsFinder across 6 cities in 26 countries. The largest study group is Not Applicable with 15 trials, with the heaviest enrollment activity in Montreal, Bethesda, and New Taipei City. Lead sponsors running eczema studies include Pfizer, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, and Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).

Browse eczema trials by phase

Treatments under study

About Eczema Clinical Trials

Looking for clinical trials for Eczema? There are currently 40 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Eczema trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Eczema clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 48 trials

Recruiting
Phase 2

Effects of Treatments on Atopic Dermatitis

DermatitisEczemaSkin Diseases+2 more
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)130 enrolled1 locationNCT01631617
Recruiting

Studies of Skin Microbes in Healthy People and in People With Skin Conditions

Atopic DermatitisEczema
National Human Genome Research Institute (NHGRI)530 enrolled1 locationNCT00605878
Recruiting

Assessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic Dermatitis

atopic dermatitis (eczema)
Zhongda Hospital80 enrolled1 locationNCT07573735
Recruiting
Phase 2

Cardamom and Topical Roseomonas in Atopic Dermatitis

Atopic DermatitisEczema
National Institute of Allergy and Infectious Diseases (NIAID)120 enrolled1 locationNCT06096857
Recruiting
Phase 2

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

DermatitisAtopic DermatitisEczema Atopic Dermatitis+5 more
Apollo Therapeutics Ltd280 enrolled85 locationsNCT07599813
Recruiting
Phase 2

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

atopic dermatitis (eczema)Atopic DermatitisEczema
Inmagene LLC405 enrolled23 locationsNCT07037901
Recruiting
Phase 2

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

Atopic DermatitisEczema, Atopic
Pfizer165 enrolled10 locationsNCT07216027
Recruiting
Phase 1

Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234

EczemaAtopic Dermatitis (AD)
Arcutis Biotherapeutics, Inc.125 enrolled1 locationNCT07453602
Recruiting
Phase 2

A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)

Atopic DermatitisEczema Atopic DermatitisEczema
Turn Therapeutics110 enrolled1 locationNCT07355075
Recruiting
Not Applicable

Skin Inflammation in (Peri)Menopause: A Probiotic Intervention Proof of Concept Trial

Skin healthRosaceaMenopause+5 more
King's College London30 enrolled1 locationNCT07341087
Recruiting
Phase 3

A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

Eczema
Pfizer150 enrolled41 locationsNCT06807268
Recruiting

Evaluation by Confocal Reflectance Microscopy of the Skin Structure of Patients With Atopic Dermatitis Treated With Tralokinumab Biotherapy.

atopic dermatitis (eczema)Atopic Dermatitis (AD)
Hôpitaux Drôme Nord15 enrolled1 locationNCT07568665
Recruiting
Not Applicable

Nigella Sativa Oil for Eczematous Otitis Externa

Eczema Atopic DermatitisOtitis Externa
Bezmialem Vakif University85 enrolled1 locationNCT07525505
Recruiting

Characterization of Chronic Hand Eczema

Atopic DermatitisChronic Hand Eczema
Dr. Robert Bissonnette270 enrolled1 locationNCT05026554
Recruiting

Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers

Atopic DermatitisHidradenitis SuppurativaAcne+3 more
Innovaderm Research Inc.500 enrolled1 locationNCT05994976
Recruiting
Not Applicable

Clinical Evaluation of a Soothing Moisturizing Lotion in Individuals With Atopic Eczema

Eczema
USMARI Research & Innovation Centre15 enrolled1 locationNCT07463079
Recruiting
Phase 2

Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD

atopic dermatitis (eczema)Atopic DermatitisEczema+1 more
Corvus Pharmaceuticals, Inc.200 enrolled1 locationNCT07441395
Recruiting
Not Applicable

Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic Diseases

Environmental ExposurePollution; ExposureFunctional Gastrointestinal Disorders+13 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS280 enrolled2 locationsNCT06529913
Recruiting
Not Applicable

Flourish: Exploring the Early Infant Gut Microbiome

MicrobiotaMicrobiomeGut Microbiome+1 more
Seeding Inc250 enrolled1 locationNCT07333482
Recruiting
Not Applicable

Preventive Effect of a Dietary Supplement With Two Probiotic Limosilactobacillus Reuteri Strains on Excessive Crying and Colic in Healthy Newborns.

ColicHealthy infantsEczema Atopic Dermatitis
Universitair Ziekenhuis Brussel768 enrolled1 locationNCT07347743